{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:19:18Z","timestamp":1791209958318,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metastatic breast cancer cannot be cured, and alteration of fatty acid metabolism contributes to tumor progression and metastasis. Here, we were interested in the elongation of very long-chain fatty acids protein 5 (Elovl5) in breast cancer. We observed that breast cancer tumors had a lower expression of Elovl5 than normal breast tissues. Furthermore, low expression of Elovl5 is associated with a worse prognosis in ER\n                    <jats:sup>+<\/jats:sup>\n                    breast cancer patients. In accordance with this finding, decrease of Elovl5 expression was more pronounced in ER\n                    <jats:sup>+<\/jats:sup>\n                    breast tumors from patients with metastases in lymph nodes. Although downregulation of Elovl5 expression limited breast cancer cell proliferation and cancer progression, suppression of Elovl5 promoted EMT, cell invasion and lung metastases in murine breast cancer models. The loss of Elovl5 expression induced upregulation of TGF-\u03b2 receptors mediated by a lipid-droplet accumulation-dependent Smad2 acetylation. As expected, inhibition of TGF-\u03b2 receptors restored proliferation and dampened invasion in low Elovl5 expressing cancer cells. Interestingly, the abolition of lipid-droplet formation by inhibition of diacylglycerol acyltransferase activity reversed induction of TGF-\u03b2 receptors, cell invasion, and lung metastasis triggered by Elovl5 knockdown. Altogether, we showed that Elovl5 is involved in metastasis through lipid droplets-regulated TGF-\u03b2 receptor expression and is a predictive biomarker of metastatic ER\n                    <jats:sup>+<\/jats:sup>\n                    breast cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-022-05209-6","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:02:58Z","timestamp":1662094978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-\u03b2 receptors"],"prefix":"10.1038","volume":"13","author":[{"given":"Trinh-Le-Vi","family":"Kieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Derang\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Perrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Truntzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Causse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Groetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9lie","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6133-1362","authenticated-orcid":false,"given":"Laurent","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul Pais","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-438X","authenticated-orcid":false,"given":"Lionel","family":"Apetoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8831-145X","authenticated-orcid":false,"given":"C\u00e9dric","family":"R\u00e9b\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeric","family":"Limagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Jourdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Demizieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-6698","authenticated-orcid":false,"given":"Charles","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-8305","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Ghiringhelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Rialland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"5209_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"5209_CR2","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8:e1027\u201337.","journal-title":"Lancet Glob Health"},{"key":"5209_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fonc.2020.00650","volume":"10","author":"P Ji","year":"2020","unstructured":"Ji P, Gong Y, Jin ML, Hu X, Di GH, Shao ZM. The burden and trends of breast cancer from 1990 to 2017 at the global, regional, and national levels: results from the global burden of disease study 2017. Front Oncol. 2020;10:650.","journal-title":"Front Oncol"},{"key":"5209_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJMoa052933","volume":"355","author":"C Fan","year":"2006","unstructured":"Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006;355:560\u20139.","journal-title":"N Engl J Med"},{"key":"5209_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature"},{"key":"5209_CR6","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5209_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.breast.2020.04.009","volume":"52","author":"S Frank","year":"2020","unstructured":"Frank S, Carton M, Dubot C, Campone M, Pistilli B, Dalenc F, et al. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast. 2020;52:50\u201357.","journal-title":"Breast"},{"key":"5209_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"5209_CR9","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/1873-3468.13451","volume":"593","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang DH, Park HG, Yan Y, Goykhman Y, Lawrence P, et al. Identification of genes mediating branched chain fatty acid elongation. FEBS Lett. 2019;593:1807\u201317.","journal-title":"FEBS Lett"},{"key":"5209_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.breast.2018.03.002","volume":"39","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Spence D, Mertz S, Corneliussen-James D, Sabelko K, Gralow J, et al. Global analysis of advanced\/metastatic breast cancer: decade report (2005-2015). Breast. 2018;39:131\u20138.","journal-title":"Breast"},{"key":"5209_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep45411","volume":"7","author":"Y Gong","year":"2017","unstructured":"Gong Y, Liu YR, Ji P, Hu X, Shao ZM. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Sci Rep. 2017;7:45411.","journal-title":"Sci Rep."},{"key":"5209_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5209_CR13","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-10-3894","volume":"71","author":"M Hilvo","year":"2011","unstructured":"Hilvo M, Denkert C, Lehtinen L, M\u00fcller B, Brockm\u00f6ller S, Sepp\u00e4nen-Laakso T, et al. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res. 2011;71:3236\u201345.","journal-title":"Cancer Res"},{"key":"5209_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.7150\/ijbs.7357","volume":"10","author":"J Li","year":"2014","unstructured":"Li J, Dong L, Wei D, Wang X, Zhang S, Li H. Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells. Int J Biol Sci. 2014;10:171\u201380.","journal-title":"Int J Biol Sci"},{"key":"5209_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cmet.2017.09.018","volume":"26","author":"M Rios Garcia","year":"2017","unstructured":"Rios Garcia M, Steinbauer B, Srivastava K, Singhal M, Mattijssen F, Maida A, et al. Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence. Cell Metab. 2017;26:842\u2013855.e845.","journal-title":"Cell Metab"},{"key":"5209_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/bjc.2017.374","volume":"118","author":"K Stoiber","year":"2018","unstructured":"Stoiber K, Nag\u0142o O, Pernpeintner C, Zhang S, Koeberle A, Ulrich M, et al. Targeting de novo lipogenesis as a novel approach in anti-cancer therapy. Br J Cancer. 2018;118:43\u201351.","journal-title":"Br J Cancer"},{"key":"5209_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Mart\u00edn M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41\u201345.","journal-title":"Nature"},{"key":"5209_CR18","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3892\/or.2017.5864","volume":"38","author":"J Zhao","year":"2017","unstructured":"Zhao J, Zhi Z, Wang C, Xing H, Song G, Yu X, et al. Exogenous lipids promote the growth of breast cancer cells via CD36. Oncol Rep. 2017;38:2105\u201315.","journal-title":"Oncol Rep."},{"key":"5209_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3554-4","volume":"17","author":"Y Yamashita","year":"2017","unstructured":"Yamashita Y, Nishiumi S, Kono S, Takao S, Azuma T, Yoshida M. Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer. BMC Cancer. 2017;17:589.","journal-title":"BMC Cancer"},{"key":"5209_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1042\/bj3500765","volume":"350","author":"AE Leonard","year":"2000","unstructured":"Leonard AE, Bobik EG, Dorado J, Kroeger PE, Chuang LT, Thurmond JM, et al. Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids. Biochem J. 2000;350:765\u201370.","journal-title":"Biochem J"},{"key":"5209_CR21","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/0008-5472.CAN-20-2511","volume":"81","author":"MM Centenera","year":"2021","unstructured":"Centenera MM, Scott JS, Machiels J, Nassar ZD, Miller DC, Zinonos I, et al. ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer. Cancer Res. 2021;81:1704\u201318.","journal-title":"Cancer Res"},{"key":"5209_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0002-9440(10)63568-7","volume":"163","author":"EY Lin","year":"2003","unstructured":"Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol. 2003;163:2113\u201326.","journal-title":"Am J Pathol"},{"key":"5209_CR23","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8:5574\u20136.","journal-title":"Cancer Med"},{"key":"5209_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2297-3","volume":"11","author":"ALS Cruz","year":"2020","unstructured":"Cruz ALS, Barreto EA, Fazolini NPB, Viola JPB, Bozza PT. Lipid droplets: platforms with multiple functions in cancer hallmarks. Cell Death Dis. 2020;11:105.","journal-title":"Cell Death Dis"},{"key":"5209_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","volume":"19","author":"CJ David","year":"2018","unstructured":"David CJ, Massagu\u00e9 J. Contextual determinants of TGF\u03b2 action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018;19:419\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5209_CR26","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3892\/etm.2017.4557","volume":"14","author":"G Wang","year":"2017","unstructured":"Wang G, Yin T. Rapamycin enhances the antiproliferative effect of transforming growth factor-\u03b2 on MCF-7 human breast cancer cells. Exp Ther Med. 2017;14:748\u201352.","journal-title":"Exp Ther Med"},{"key":"5209_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1878-0261.12162","volume":"12","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Ma J, Fan Y, Wang Z, Tian R, Ji W, et al. TGF-\u03b2 transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK\/Sp1 signaling pathways. Mol Oncol. 2018;12:305\u201321.","journal-title":"Mol Oncol"},{"key":"5209_CR28","doi-asserted-by":"crossref","unstructured":"Al Ameri W, Ahmed I, Al-Dasim FM, Ali Mohamoud Y, Al-Azwani IK, Malek JA, et al. Cell type-specific TGF-\u03b2 mediated EMT in 3D and 2D models and its reversal by TGF-\u03b2 receptor kinase inhibitor in ovarian cancer cell lines. Int J Mol Sci. 2019;20:3568.","DOI":"10.3390\/ijms20143568"},{"key":"5209_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s13046-021-02188-y","volume":"40","author":"Y Huang","year":"2021","unstructured":"Huang Y, Chen Z, Lu T, Bi G, Li M, Liang J, et al. HIF-1\u03b1 switches the functionality of TGF-\u03b2 signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer. J Exp Clin Cancer Res. 2021;40:398.","journal-title":"J Exp Clin Cancer Res"},{"key":"5209_CR30","doi-asserted-by":"crossref","unstructured":"Soukupova J, Malfettone A, Bertran E, Hern\u00e1ndez-Alvarez MI, Pe\u00f1uelas-Haro I, Dituri F, et al. Epithelial-mesenchymal transition (EMT) induced by TGF-\u03b2 in hepatocellular carcinoma cells reprograms lipid metabolism. Int J Mol Sci. 2021;22:5543.","DOI":"10.3390\/ijms22115543"},{"key":"5209_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-00436-9","volume":"6","author":"S Liu","year":"2021","unstructured":"Liu S, Ren J, Ten Dijke P. Targeting TGF\u03b2 signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:8.","journal-title":"Signal Transduct Target Ther"},{"key":"5209_CR32","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1158\/1078-0432.CCR-17-3322","volume":"24","author":"SC Formenti","year":"2018","unstructured":"Formenti SC, Lee P, Adams S, Goldberg JD, Li X, Xie MW, et al. Focal irradiation and systemic TGF\u03b2 blockade in metastatic breast cancer. Clin Cancer Res. 2018;24:2493\u2013504.","journal-title":"Clin Cancer Res"},{"key":"5209_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.onc.1208174","volume":"24","author":"PM Alli","year":"2005","unstructured":"Alli PM, Pinn ML, Jaffee EM, McFadden JM, Kuhajda FP. Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene. 2005;24:39\u201346.","journal-title":"Oncogene"},{"key":"5209_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0107-x","volume":"7","author":"Y Liang","year":"2018","unstructured":"Liang Y, Han H, Liu L, Duan Y, Yang X, Ma C, et al. CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells. Oncogenesis. 2018;7:98.","journal-title":"Oncogenesis"},{"key":"5209_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/1878-0261.12368","volume":"12","author":"S Balaban","year":"2018","unstructured":"Balaban S, Lee LS, Varney B, Aishah A, Gao Q, Shearer RF, et al. Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis. Mol Oncol. 2018;12:1623\u201338.","journal-title":"Mol Oncol"},{"key":"5209_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05433-7","volume":"7","author":"B Jun","year":"2017","unstructured":"Jun B, Mukherjee PK, Asatryan A, Kautzmann MA, Heap J, Gordon WC, et al. Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity. Sci Rep. 2017;7:5279.","journal-title":"Sci Rep."},{"key":"5209_CR37","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1038\/s41388-021-01959-3","volume":"40","author":"F Rugolo","year":"2021","unstructured":"Rugolo F, Bazan NG, Calandria J, Jun B, Raschell\u00e0 G, Melino G, et al. The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome. Oncogene. 2021;40:5741\u201351.","journal-title":"Oncogene"},{"key":"5209_CR38","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1158\/1078-0432.CCR-15-2973","volume":"22","author":"F Geng","year":"2016","unstructured":"Geng F, Cheng X, Wu X, Yoo JY, Cheng C, Guo JY, et al. Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis. Clin Cancer Res. 2016;22:5337\u201348.","journal-title":"Clin Cancer Res"},{"key":"5209_CR39","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3892\/ol.2020.11769","volume":"20","author":"C Jin","year":"2020","unstructured":"Jin C, Yuan P. Implications of lipid droplets in lung cancer: associations with drug resistance. Oncol Lett. 2020;20:2091\u2013104.","journal-title":"Oncol Lett"},{"key":"5209_CR40","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41374-019-0296-8","volume":"99","author":"F Nardi","year":"2019","unstructured":"Nardi F, Fitchev P, Brooks KM, Franco OE, Cheng K, Hayward SW, et al. Lipid droplet velocity is a microenvironmental sensor of aggressive tumors regulated by V-ATPase and PEDF. Lab Investig. 2019;99:1822\u201334.","journal-title":"Lab Investig"},{"key":"5209_CR41","first-page":"4112","volume":"10","author":"Z Li","year":"2020","unstructured":"Li Z, Liu H, Luo X. Lipid droplet and its implication in cancer progression. Am J Cancer Res. 2020;10:4112\u201322.","journal-title":"Am J Cancer Res"},{"key":"5209_CR42","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1039\/C4AN01875C","volume":"140","author":"H Abramczyk","year":"2015","unstructured":"Abramczyk H, Surmacki J, Kope\u0107 M, Olejnik AK, Lubecka-Pietruszewska K, Fabianowska-Majewska K. The role of lipid droplets and adipocytes in cancer. Raman imaging of cell cultures: MCF10A, MCF7, and MDA-MB-231 compared to adipocytes in cancerous human breast tissue. Analyst. 2015;140:2224\u201335.","journal-title":"Analyst"},{"key":"5209_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10585-011-9405-9","volume":"28","author":"CJ Antalis","year":"2011","unstructured":"Antalis CJ, Uchida A, Buhman KK, Siddiqui RA. Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification. Clin Exp Metastasis. 2011;28:733\u201341.","journal-title":"Clin Exp Metastasis"},{"key":"5209_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14262-3","volume":"11","author":"C Corbet","year":"2020","unstructured":"Corbet C, Bastien E, Santiago de Jesus JP, Dierge E, Martherus R, Vander Linden C, et al. TGF\u03b22-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells. Nat Commun. 2020;11:454.","journal-title":"Nat Commun"},{"key":"5209_CR45","first-page":"27","volume":"21","author":"S Xu","year":"2021","unstructured":"Xu S, Chen T, Dong L, Li T, Xue H, Gao B, et al. Fatty acid synthase promotes breast cancer metastasis by mediating changes in fatty acid metabolism. Oncol Lett. 2021;21:27.","journal-title":"Oncol Lett"},{"key":"5209_CR46","doi-asserted-by":"crossref","unstructured":"Petan T, Jarc E, Jusovi\u0107 M. Lipid droplets in cancer: guardians of fat in a stressful world. Molecules. 2018;23:1941.","DOI":"10.3390\/molecules23081941"},{"key":"5209_CR47","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/ijc.32924","volume":"147","author":"B Englinger","year":"2020","unstructured":"Englinger B, Laemmerer A, Moser P, Kallus S, R\u00f6hrl C, Pirker C, et al. Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib. Int J Cancer. 2020;147:1680\u201393.","journal-title":"Int J Cancer"},{"key":"5209_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4757-z","volume":"18","author":"S Hultsch","year":"2018","unstructured":"Hultsch S, Kankainen M, Paavolainen L, Kovanen RM, Ikonen E, Kangaspeska S, et al. Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC Cancer. 2018;18:850.","journal-title":"BMC Cancer"},{"key":"5209_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mce.2012.08.005","volume":"363","author":"IR Schlaepfer","year":"2012","unstructured":"Schlaepfer IR, Hitz CA, Gij\u00f3n MA, Bergman BC, Eckel RH, Jacobsen BM. Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel. Mol Cell Endocrinol. 2012;363:111\u201321.","journal-title":"Mol Cell Endocrinol"},{"key":"5209_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.","journal-title":"Sci Rep."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05209-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05209-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05209-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:03:09Z","timestamp":1662094989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05209-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["5209"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05209-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"758"}}